Mary Jane Raymond
Analyst · Cowen. Please go ahead
Thank you, Bob, and good morning. First of all, a sincere thank you to all of our customers who pay the II-VI is the underlying driver of our growth. We are honored to support your strategic goals. Our Q4 revenue was $808 million was geographically distributed as follows: 48% in North America, 23% in China, 20% in Europe, 6% in Japan and 3% in the rest of the world. For the full-year, geographic distribution was 50% North America, 22% china, 18% Europe, 7% Japan and 3% for the rest of the world. In the quarter, end market revenue distribution was 67% in Communications, 13% in industrial, including automotive, 7% in aerospace and defense, 5% in consumer for semiconductor capital equipment, 3% in life sciences and the remainder is in other end market. Our non-GAAP gross margin was 38.6% and the non-GAAP operating margin was 18.4%. The non-GAAP gross margin and the non-GAAP operating margin remained well ahead of the margin II-VI achieved right before the acquisition of Finisar closed. We incurred $4 million of COVID expenses in the quarter, of which $2 million is included in the non-GAAP. This total includes lost work time and overtime and collectively, these costs put downward pressure on the gross and operating margins in the quarter. We also incurred $3.3 million of costs to deal with supply chain shortages, including expedited freight and unusual price increases above our costs in the ordinary course. This $3.3 million is included in the non-GAAP adjustments. At the segment level, the non-GAAP operating margins were 15.9% for Photonics and 23.7% for compound semiconductors. Similar to last quarter, compounded margins were driven by a strong mix and optimized capacity utilization. Our record backlog of $1.25 billion consists of $827 million for Photonics and $425 million for compound semiconductors. The backlog consists of orders that will ship over the next 12-months. We have, of course, many orders that extend beyond 12-months as customers attempt to secure capacity for what many consider to be a super cycle. GAAP operating expenses, which are SG&A plus R&D, were $211 million in Q4. Excluding $21 million of amortization, $16 million of stock comp and $12 million of M&A and integration costs non-GAAP OpEx was $162 million or 20% of revenue and 600 basis points below the OpEx percent of revenue just prior to the close of the acquisition when it was nearly 26% for II-VI and Finisar combined, excluding amortization, stock comp and transaction costs. These improvements are driven by our accelerated achievement of synergies, including productivity improvements and moving manufacturing to lower cost areas of operation. Quarterly GAAP EPS was $0.59 and non-GAAP EPS was $0.88 with after tax non-GAAP adjustments of $35 million in total, including the reversal of the positive investment gains. The diluted share count for GAAP results is 116 million shares. For non-GAAP results, the diluted share count was 125 million shares. The GAAP and non-GAAP EPS calculations are in the last two tables of our press release. Stock comp was $19 million for the quarter, [$3 billion in COGS] (Ph) and $16 million in OpEx. We expect stock comp for Q1 to be $22 million. Cash flow from operations in the quarter was $127 million and free cash flow was $83 million. We paid down $15 million of our debt in Q4 and our net cash position is $175 million. The interest expense in the quarter was $14 million. For the full-year, cash flow from operations was $574 million. Free cash flow was $428 million. DSO was 68-days, and the company’s liquidity at June 30th was $2 billion. Capital expenditures this quarter were $42 million. For the year, CapEx was $146 million. For fiscal year 2022, we expect CapEx to be between $325 million and $375 million. As part of the management of our strategic equity investment portfolio, the company reported a gain of $7 million on the sale of an equity investment in Sweden and a $3.9 million gain on the IPO of a portion of another investment, this one in China. The $3.9 million gain relates to a minority position we took over a decade ago. Depreciation was $50 million in the quarter and we expect our forward depreciation expense to be about $50 million to $55 million a quarter. FX was a loss of $1.3 million, primarily driven by the Swiss franc and the RMB. The effective tax rate in the quarter was 12% and due to ongoing benefits of renewed high-tech status in several countries, lower GILTI income due to the favorable mix of earnings around the world and increased stock compensation exercises. We expect the tax rate to be between 19% and 21% for fiscal year 2022. We had $12 million in cost for M&A, integration and other costs largely for Coherent and Finisar. With respect to our Series B preferred stock issuance, we recorded a $10 million dividend in Q4 that will be deducted from net income in the same manner that the $6.9 million dividend is deducted for the Series A preferred stock. Turning to the outlook for Q1 fiscal year 2022. Our outlook for revenue for the first fiscal quarter ending September 30, 2021, is expected to be $780 million to $830 million and earnings per share on a non-GAAP basis at $0.75 to $0.90 and at 118 million shares. For Q1, we expect both the Series A and the Series B preferred stock to be anti-dilutive so you should deduct $17 million from your calculated non-GAAP net income to arrive at net income available to common shareholders, then divide that by 118 million shares to arrive at non-GAAP EPS. This is how the above EPS range is calculated. This is at today’s exchange rate and an estimated tax rate of 20%. The EPS range also includes our investment of up to $20 million for silicon carbide expansion. For the non-GAAP earnings per share, we add back to the GAAP earnings pretax amounts of $21 million in amortization, $22 million in stock comp and $11 million to $15 million in transaction and integration costs. The estimated Q1 share count is 111 million shares for GAAP and 118 million shares for non-GAAP. The actual dollar amount of non-GAAP items, the exchange rate, the tax rate and the share count are all subject to change. Before we go to Q&A, just as a reminder, our answers today may contain forecasts from which our actual results may differ due to a variety of factors, including, but not limited to, product mix, customer orders, supply chain shortages, both upstream and downstream, competition, changes in regulation, ongoing requirements to combat the COVID-19 virus and general economic conditions. We would also ask that each firm limit its questions to one question with no follow-up as we would like to try to get everyone in during this call. We expect to end this call, not later than 10:15 a.m. Regina, you may open the line for questions.